Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sensus Healthcare (SRTS) Income towards Parent Company (2016 - 2025)

Sensus Healthcare has reported Income towards Parent Company over the past 10 years, most recently at -$3.2 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company fell 304.85% year-over-year to -$3.2 million; the TTM value through Dec 2025 reached -$7.7 million, down 216.13%, while the annual FY2025 figure was -$7.7 million, 216.13% down from the prior year.
  • Income towards Parent Company for Q4 2025 was -$3.2 million at Sensus Healthcare, down from -$943000.0 in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $16.1 million in Q1 2022 and troughed at -$3.2 million in Q4 2025.
  • A 5-year average of $1.4 million and a median of $705000.0 in 2021 define the central range for Income towards Parent Company.
  • Biggest five-year swings in Income towards Parent Company: soared 1945.2% in 2021 and later crashed 304.85% in 2025.
  • Year by year, Income towards Parent Company stood at $5.3 million in 2021, then plummeted by 46.8% to $2.8 million in 2022, then soared by 48.82% to $4.2 million in 2023, then plummeted by 63.28% to $1.5 million in 2024, then crashed by 304.85% to -$3.2 million in 2025.
  • Business Quant data shows Income towards Parent Company for SRTS at -$3.2 million in Q4 2025, -$943000.0 in Q3 2025, and -$1.0 million in Q2 2025.